Literature DB >> 24508537

Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-κB signaling pathway in lipopolysaccharide-induced mastitis in mice.

Yunhe Fu1, Ruifeng Gao1, Yongguo Cao1, Mengyao Guo1, Zhengkai Wei1, Ershun Zhou1, Yimeng Li1, Minjun Yao1, Zhengtao Yang1, Naisheng Zhang2.   

Abstract

Curcumin, the main constituent of the spice turmeric, has been reported to have potent anti-inflammatory properties. However, the effect of curcumin on lipopolysaccharide (LPS)-induced mice mastitis has not been investigated. The aim of this study was to investigate whether curcumin could ameliorate the inflammation response in LPS-induced mice mastitis and to clarify the possible mechanism. The mouse model of mastitis was induced by injection of LPS through the duct of the mammary gland. Curcumin was applied 1h before and 12h after LPS treatment. The results showed that curcumin attenuated the infiltration of inflammatory cells, the activity of myeloperoxidase (MPO), and the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in a dose-dependent manner. Additionally, Western blotting results showed that curcumin inhibited the phosphorylation of IκB-α and NF-κB p65 and the expression of TLR4. These results indicated that curcumin has protective effect on mice mastitis and the anti-inflammatory mechanism of curcumin on LPS-induced mastitis in mice may be due to its ability to inhibit TLR4-mediated NF-κB signaling pathways. Curcumin may be a potential therapeutic agent against mastitis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Curcumin; Mastitis; Myeloperoxidase; Nuclear factor-kappa B (NF-κB); TLR4

Mesh:

Substances:

Year:  2014        PMID: 24508537     DOI: 10.1016/j.intimp.2014.01.024

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  24 in total

1.  Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.

Authors:  Neha Sharma; Sheetal Sharma; Bimla Nehru
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

2.  The Effect of Nano-Curcumin Supplementation on Pentraxin 3 Gene Expression and Serum Level in Migraine Patients.

Authors:  Mona Djalali; Mahmoud Djalali; Mina Abdolahi; Hamed Mohammadi; Hajar Heidari; Shayesteh Hosseini; Majid Sadeghizadeh
Journal:  Rep Biochem Mol Biol       Date:  2020-04

3.  Lycium barbarum polysaccharides alleviate LPS-induced inflammatory responses through PPARγ/MAPK/NF-κB pathway in bovine mammary epithelial cells.

Authors:  Tianle Xu; Run Liu; Xubin Lu; Xinyue Wu; Petr Heneberg; Yongjiang Mao; Qianming Jiang; Juan Loor; Zhangping Yang
Journal:  J Anim Sci       Date:  2022-01-01       Impact factor: 3.159

4.  Genome-wide post-transcriptional regulation of bovine mammary gland response to Streptococcus uberis.

Authors:  Raana Tabashiri; Somayeh Sharifi; Abbas Pakdel; Mohammad Reza Bakhtiarizadeh; Mohammad Hossein Pakdel; Ahmad Tahmasebi; Colin Hercus
Journal:  J Appl Genet       Date:  2022-09-06       Impact factor: 2.653

5.  Curcumin Improved Intestinal Epithelial Barrier Integrity by Up-Regulating ZO-1/Occludin/Claudin-1 in Septic Rats.

Authors:  Xiaofeng Liu; Hongquan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-07       Impact factor: 2.650

Review 6.  Inflammatory mediators in mastitis and lactation insufficiency.

Authors:  Wendy V Ingman; Danielle J Glynn; Mark R Hutchinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-25       Impact factor: 2.673

7.  Oxymatrine lightened the inflammatory response of LPS-induced mastitis in mice through affecting NF-κB and MAPKs signaling pathways.

Authors:  Zhengtao Yang; Ronglan Yin; Yunfeng Cong; Zhanqing Yang; Ershun Zhou; Zhengkai Wei; Zhicheng Liu; Yongguo Cao; Naisheng Zhang
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

8.  Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial.

Authors:  Franchek Drobnic; Joan Riera; Giovanni Appendino; Stefano Togni; Federico Franceschi; Xavier Valle; Antoni Pons; Josep Tur
Journal:  J Int Soc Sports Nutr       Date:  2014-06-18       Impact factor: 5.150

9.  Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFκB signaling and macrophage migration.

Authors:  Nicholas A Young; Michael S Bruss; Mark Gardner; William L Willis; Xiaokui Mo; Giancarlo R Valiente; Yu Cao; Zhongfa Liu; Wael N Jarjour; Lai-Chu Wu
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 10.  Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

Authors:  Wenhao Weng; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-02-20       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.